Search clinical trials for: neurogenic bladder

Total 3955 results

Allergan

Completed

Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)

Multiple Sclerosis | Urinary Incontinence | Neurogenic Bladder

France, Poland, Portugal, Belgium, Canada, Russian Federation, Czechia, United States
University of Zurich
Swiss National Science Foundation; Balgrist University Hospital

Completed

Supraspinal Control of Lower Urinary Tract Function in Healthy Controls and Patients With Bladder Dysfunction

Multiple Sclerosis | Overactive Bladder | Spinal Cord Injury | Neurogenic Lower Urinary Tract Dysfunction

Switzerland
Spinal Singularity

Completed

Connected Catheter (C2P) Study for Bladder Management

Urinary Retention | Neurogenic Bladder

United States
Lawson Health Research Institute

Terminated

Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients

Urinary Bladder, Neurogenic

Canada
MedtronicNeuro

Terminated

Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder (ACCEPTANCE)

Urinary Incontinence | Detrusor Overactivity | Neurogenic Overactive Bladder

Belgium, France, United Kingdom, Germany, Italy, Netherlands
Astellas Pharma Europe B.V.

Completed

A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)

Pediatric | Neurogenic Detrusor Overactivity

United States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
Astellas Pharma Inc

Completed

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Overactive Bladder | Neurogenic Detrusor Overactivity

Belgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
Hospital Universitário Professor Edgard Santos

Completed

Urological Physical Therapy in HTLV-1 With Urinary Symptoms (UROHTLV)

Tropical Spastic Paraparesis | HTLV-1

Brazil
Spinal Singularity

Completed

Connected Catheter Clinical Feasibility Study( CFS)

Urinary Bladder, Neurogenic

United States
Sally E. Wenzel MD

Withdrawn

Anti-Inflammatory Lipid Mediators in Asthma (ALMA)

Asthma

United States
Edgar LeClaire, MD

Completed

Reduction of Bladder Injection Pain With Belladonna Opiate Suppository (ROBIN)

Overactive Bladder | Urinary Bladder, Neurogenic | Painful Bladder Syndrome | Urinary Urge Incontinence

United States
The University of Texas Health Science Center,...
Baylor College of Medicine; University of Houston; Case Western Reserve University and other collaborators

Completed

The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury

Spinal Cord Injury | Neurogenic Bladder

United States
Saint-Joseph University

Unknown

Urinary Disorders in Patients With Multiple Sclerosis: Invasive Vs Non-invasive Investigations.

Multiple Sclerosis | Urinary Bladder, Neurogenic | Urodynamics

Lebanon
Tengion

Terminated

Study of Autologous Neo-Bladder Construct in Subjects With Neurogenic Bladder Following Spinal Cord Injury

Neurogenic Bladder

United States
Shriners Hospitals for Children

Completed

Use of a Diurnal Indwelling Urethral Catheter to Improve Quality of Life

Neurogenic Bladder | Spina Bifida
Tengion

Withdrawn

Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence

Overactive Bladder

United States
Hospital de Clinicas de Porto Alegre

Completed

Can Dynamic Ultrasonography Replace Urodynamics in Follow-up of Patients With Myelomeningocele

Myelomeningocele | Neurogenic Bladder
Allergan

Completed

A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India

Overactive Bladder | Urinary Incontinence

India
Balgrist University Hospital

Completed

Detrusor Contraction During the Ice-water-test

Urinary Bladder, Neurogenic | Neuropathic Bladder

Switzerland
Complexa, Inc.

Completed

Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury

Acute Kidney Injury (Nontraumatic)

United States
AHMED FARAHAT HASSAN

Unknown

The Efficacy of Botulinum Toxin in Spastic Neuropathic Bladder

Spastic Neurogenic Bladder

Egypt
Dr. Gaines W. Hammond Jr. MD FACS

Unknown

A Prospective Evaluation of the Catheter Science C3 "Umbrella Catheter."

Urinary Retention | Urinary Bladder, Neurogenic | Intermittent Catheterization

United States
University of Michigan
U.S. Department of Education

Completed

Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)

Urinary Bladder, Neurogenic | Neurogenic Bowel | Injuries, Spinal Cord

United States
Astellas Pharma Inc

Completed

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis (SONIC)

Multiple Sclerosis | Spinal Cord Diseases | Neurogenic Bladder

Australia, France, Belgium, Germany, Netherlands, Italy, Spain, United Kingdom, Hungary, Czechia, Russian Federation
Buddhist Tzu Chi General Hospital

Completed

Effect of Botulinum Toxin A on Neurogenic Detrusor Overactivity in Chronic Spinal Cord Injured Patients

Neurogenic Bladder
Stanford University
Allergan

Completed

Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease

Urinary Incontinence | Parkinson's Disease | Neurogenic Bladder | Clostridium Botulinum Toxin Adverse Reaction

United States
University Hospital, Tours

Completed

Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder (PACHIU)

Urinary Tract Infection | Neurogenic Bladder

France
Centre d'Investigation Clinique et Technologique...

Completed

Toxin Retrospective Study (NDOTOX)

Neurogenic Bladder

France
Balgrist University Hospital

Completed

Neuro-urological Outcome After Spinal Cord Injury

Urinary Bladder Neurogenic Dysfunction

Switzerland
Balgrist University Hospital

Completed

Reflux in Spinal Cord Injury Patients With Neurogenic Lower Urinary Tract Dysfunction

Spinal Cord Injury | Vesico-ureteral Reflux

Switzerland
Balgrist University Hospital

Completed

Incidence of Urinary Tract Infection After Urodynamic Investigation

Neurogenic Bladder

Switzerland
Allergan

Completed

Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder (BOREAL)

Urinary Bladder, Overactive | Urinary Bladder, Neurogenic

France
Coloplast A/S

Completed

Quality of Life Intermittent Catheter Study

Neurogenic Bladder Dysfunction Nos

Denmark, France, Germany, Norway, Sweden
Allergan

Completed

Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

Urinary Bladder, Overactive | Urinary Incontinence

Korea, Republic of
Allergan

Completed

A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

Overactive Bladder | Urinary Incontinence

Korea, Republic of
VA Office of Research and Development

Completed

A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection

Urinary Tract Infections | Bladder, Neurogenic

United States
Balgrist University Hospital
Swiss National Science Foundation

Completed

Heart Rate Variability (HRV) in Patients With Neurogenic Detrusor Overactivity (NDO) Before and After Botulinum Neurotoxin Type A (BoNT/A) Intradetrusor Injections (HRV/Botox)

Bladder Disorder, Neurogenic

Switzerland
Boehringer Ingelheim

Completed

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

Bladder, Neurogenic

Belgium, Spain, United States, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, India, Brazil, Canada, Mexico, Ukraine
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Overactive Bladder

United Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
Tengion

Terminated

Augmentation Cystoplasty Using an Autologous Neo-Bladder

Neurogenic Bladder

United States
Swiss Paraplegic Centre Nottwil

Completed

Representation of the Bladder Innervation Using Diffusion Tensor Imaging Fiber Tracking With MRI - a Pilot Study

Spinal Cord Injury | Neurogenic Lower Urinary Tract Dysfunction

Switzerland
Swiss Paraplegic Centre Nottwil

Completed

Effects of Antimuscarinics on Cognition in Spinal Cord Injury

Mild Cognitive Impairment | Spinal Cord Injuries

Switzerland
Swiss Paraplegic Centre Nottwil

Completed

Is the Nerve Growth Factor (NGF) a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury?

Spinal Cord Injury | Neurogenic Detrusor Overactivity | Neurogenic Lower Urinary Tract Dysfunction

Switzerland
Boehringer Ingelheim

Completed

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

Bladder, Neurogenic

Belgium, Spain, United States, India, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, Brazil, Mexico, Ukraine
Tatiane Gomes de Araujo

Unknown

Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve Electrostimulation (NOVTPD)

Overactive Bladder | Parkinson Disease

Brazil
Allergan

Terminated

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Overactive Bladder

Serbia, Turkey, Greece, Egypt, Lebanon, India
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Overactive Bladder

Portugal, South Africa, Netherlands, Canada, Singapore, Brazil, United States, Taiwan, Italy, United Kingdom, France, Spain
GlaxoSmithKline

Terminated

Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients

Overactive Bladder | Incontinence, Urinary and Urinary Bladder, Overactive

United States
Nemours Children's Clinic

Terminated

Treatment of Neurogenic Incontinence by Surgery to Cut the Filum Terminale (NICNOC)

Dysfunctional Voiding | Neurogenic Incontinence

United States
University Hospital, Rouen

Terminated

NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder

Overactive Bladder

France

Search clinical trials for: neurogenic bladder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations